1. Home
  2. ARQT vs MNDY Comparison

ARQT vs MNDY Comparison

Compare ARQT & MNDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$24.88

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Logo monday.com Ltd.

MNDY

monday.com Ltd.

HOLD

Current Price

$84.48

Market Cap

3.9B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARQT
MNDY
Founded
2016
2012
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.9B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
ARQT
MNDY
Price
$24.88
$84.48
Analyst Decision
Strong Buy
Buy
Analyst Count
6
26
Target Price
$34.00
$167.65
AVG Volume (30 Days)
1.6M
1.2M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
88.79
N/A
EPS
0.03
N/A
Revenue
$376,072,000.00
N/A
Revenue This Year
$34.85
$20.70
Revenue Next Year
$29.39
$16.48
P/E Ratio
$813.00
$34.38
Revenue Growth
91.34
N/A
52 Week Low
$16.62
$57.50
52 Week High
$31.77
$220.80

Technical Indicators

Market Signals
Indicator
ARQT
MNDY
Relative Strength Index (RSI) 47.67 43.04
Support Level $22.73 $68.05
Resistance Level $25.25 $87.95
Average True Range (ATR) 0.91 4.55
MACD -0.04 -1.06
Stochastic Oscillator 42.09 3.03

Price Performance

Historical Comparison
ARQT
MNDY

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

About MNDY monday.com Ltd.

Monday.com Ltd is an artificial intelligence work platform that runs and orchestrates the core of all work. The platform democratizes access to software, including AI, enabling organizations to easily build applications and work management tools that fit their needs. The cloud-based platform is a no-code and low-code framework built from modular building blocks that are simple enough for anyone to use, yet powerful enough to drive core business across any organization. The platform also integrates with other systems and applications, creating a connective layer for organizations that links departments and bridges information silos. In addition to the core products, it introduced four core Al work capabilities: monday sidekick, monday vibe, monday agents, and workflows.

Share on Social Networks: